nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A5—Dactinomycin—melanoma	0.281	0.373	CbGbCtD
Diphenhydramine—CYP1A2—Carmustine—melanoma	0.155	0.206	CbGbCtD
Diphenhydramine—CYP1A2—Vemurafenib—melanoma	0.123	0.163	CbGbCtD
Diphenhydramine—CYP2D6—Vemurafenib—melanoma	0.101	0.134	CbGbCtD
Diphenhydramine—CYP1A2—Dacarbazine—melanoma	0.0942	0.125	CbGbCtD
Diphenhydramine—Photosensitivity—Vemurafenib—melanoma	0.00332	0.0308	CcSEcCtD
Diphenhydramine—Chest tightness—Docetaxel—melanoma	0.00291	0.027	CcSEcCtD
Diphenhydramine—Wheezing—Bleomycin—melanoma	0.00237	0.0219	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Vemurafenib—melanoma	0.0023	0.0213	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Vemurafenib—melanoma	0.0022	0.0204	CcSEcCtD
Diphenhydramine—Neuritis—Docetaxel—melanoma	0.00183	0.0169	CcSEcCtD
Diphenhydramine—Chills—Vemurafenib—melanoma	0.00181	0.0168	CcSEcCtD
Diphenhydramine—Nasal congestion—Temozolomide—melanoma	0.00164	0.0152	CcSEcCtD
Diphenhydramine—Chest discomfort—Docetaxel—melanoma	0.00154	0.0143	CcSEcCtD
Diphenhydramine—Diplopia—Carmustine—melanoma	0.00154	0.0143	CcSEcCtD
Diphenhydramine—Diplopia—Temozolomide—melanoma	0.00149	0.0138	CcSEcCtD
Diphenhydramine—Hypotension—Vemurafenib—melanoma	0.00134	0.0124	CcSEcCtD
Diphenhydramine—Bifonazole—CYP17A1—melanoma	0.0013	0.206	CrCbGaD
Diphenhydramine—Sweating increased—Temozolomide—melanoma	0.00126	0.0116	CcSEcCtD
Diphenhydramine—Decreased appetite—Vemurafenib—melanoma	0.00125	0.0115	CcSEcCtD
Diphenhydramine—Fatigue—Vemurafenib—melanoma	0.00124	0.0114	CcSEcCtD
Diphenhydramine—Constipation—Vemurafenib—melanoma	0.00123	0.0114	CcSEcCtD
Diphenhydramine—Dysuria—Temozolomide—melanoma	0.00121	0.0112	CcSEcCtD
Diphenhydramine—Pollakiuria—Temozolomide—melanoma	0.00119	0.011	CcSEcCtD
Diphenhydramine—Agranulocytosis—Dactinomycin—melanoma	0.00119	0.011	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Temozolomide—melanoma	0.00118	0.0109	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Carmustine—melanoma	0.00117	0.0108	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Temozolomide—melanoma	0.00113	0.0104	CcSEcCtD
Diphenhydramine—Chills—Bleomycin—melanoma	0.0011	0.0102	CcSEcCtD
Diphenhydramine—Asthenia—Vemurafenib—melanoma	0.00103	0.00952	CcSEcCtD
Diphenhydramine—Chills—Dactinomycin—melanoma	0.00102	0.00947	CcSEcCtD
Diphenhydramine—Diarrhoea—Vemurafenib—melanoma	0.000982	0.00908	CcSEcCtD
Diphenhydramine—Tinnitus—Temozolomide—melanoma	0.000962	0.0089	CcSEcCtD
Diphenhydramine—Dizziness—Vemurafenib—melanoma	0.000949	0.00878	CcSEcCtD
Diphenhydramine—Chills—Temozolomide—melanoma	0.000926	0.00857	CcSEcCtD
Diphenhydramine—Vomiting—Vemurafenib—melanoma	0.000912	0.00844	CcSEcCtD
Diphenhydramine—Rash—Vemurafenib—melanoma	0.000904	0.00837	CcSEcCtD
Diphenhydramine—Dermatitis—Vemurafenib—melanoma	0.000904	0.00836	CcSEcCtD
Diphenhydramine—Headache—Vemurafenib—melanoma	0.000899	0.00832	CcSEcCtD
Diphenhydramine—Confusional state—Bleomycin—melanoma	0.000876	0.00811	CcSEcCtD
Diphenhydramine—Vision blurred—Carmustine—melanoma	0.000876	0.00811	CcSEcCtD
Diphenhydramine—Tremor—Carmustine—melanoma	0.000871	0.00806	CcSEcCtD
Diphenhydramine—Agitation—Carmustine—melanoma	0.000854	0.0079	CcSEcCtD
Diphenhydramine—Nausea—Vemurafenib—melanoma	0.000852	0.00788	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Bleomycin—melanoma	0.000851	0.00787	CcSEcCtD
Diphenhydramine—Vision blurred—Temozolomide—melanoma	0.000847	0.00783	CcSEcCtD
Diphenhydramine—Tremor—Temozolomide—melanoma	0.000842	0.00779	CcSEcCtD
Diphenhydramine—Anorexia—Bleomycin—melanoma	0.000828	0.00767	CcSEcCtD
Diphenhydramine—Agitation—Temozolomide—melanoma	0.000826	0.00764	CcSEcCtD
Diphenhydramine—Hypotension—Bleomycin—melanoma	0.000812	0.00751	CcSEcCtD
Diphenhydramine—Vertigo—Temozolomide—melanoma	0.000807	0.00747	CcSEcCtD
Diphenhydramine—Convulsion—Carmustine—melanoma	0.000805	0.00745	CcSEcCtD
Diphenhydramine—Palpitations—Temozolomide—melanoma	0.000794	0.00735	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dactinomycin—melanoma	0.000794	0.00734	CcSEcCtD
Diphenhydramine—Paraesthesia—Bleomycin—melanoma	0.00078	0.00722	CcSEcCtD
Diphenhydramine—Convulsion—Temozolomide—melanoma	0.000778	0.0072	CcSEcCtD
Diphenhydramine—Anorexia—Dactinomycin—melanoma	0.000773	0.00715	CcSEcCtD
Diphenhydramine—Confusional state—Carmustine—melanoma	0.000765	0.00708	CcSEcCtD
Diphenhydramine—Decreased appetite—Bleomycin—melanoma	0.000756	0.00699	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Docetaxel—melanoma	0.000749	0.00693	CcSEcCtD
Diphenhydramine—Dry mouth—Temozolomide—melanoma	0.000748	0.00692	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Carmustine—melanoma	0.000743	0.00687	CcSEcCtD
Diphenhydramine—Tachycardia—Carmustine—melanoma	0.00074	0.00685	CcSEcCtD
Diphenhydramine—Confusional state—Temozolomide—melanoma	0.000739	0.00684	CcSEcCtD
Diphenhydramine—Anorexia—Carmustine—melanoma	0.000723	0.00669	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Temozolomide—melanoma	0.000718	0.00664	CcSEcCtD
Diphenhydramine—Feeling abnormal—Bleomycin—melanoma	0.000716	0.00663	CcSEcCtD
Diphenhydramine—Agranulocytosis—Docetaxel—melanoma	0.000713	0.0066	CcSEcCtD
Diphenhydramine—Hypotension—Carmustine—melanoma	0.000709	0.00656	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Temozolomide—melanoma	0.000709	0.00656	CcSEcCtD
Diphenhydramine—Decreased appetite—Dactinomycin—melanoma	0.000705	0.00652	CcSEcCtD
Diphenhydramine—Fatigue—Dactinomycin—melanoma	0.000699	0.00647	CcSEcCtD
Diphenhydramine—Anorexia—Temozolomide—melanoma	0.000699	0.00647	CcSEcCtD
Diphenhydramine—Urticaria—Bleomycin—melanoma	0.00069	0.00639	CcSEcCtD
Diphenhydramine—Insomnia—Carmustine—melanoma	0.000686	0.00635	CcSEcCtD
Diphenhydramine—Paraesthesia—Carmustine—melanoma	0.000681	0.0063	CcSEcCtD
Diphenhydramine—Somnolence—Carmustine—melanoma	0.000674	0.00624	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dactinomycin—melanoma	0.000668	0.00618	CcSEcCtD
Diphenhydramine—Insomnia—Temozolomide—melanoma	0.000663	0.00614	CcSEcCtD
Diphenhydramine—Decreased appetite—Carmustine—melanoma	0.000659	0.0061	CcSEcCtD
Diphenhydramine—Paraesthesia—Temozolomide—melanoma	0.000658	0.00609	CcSEcCtD
Diphenhydramine—Somnolence—Temozolomide—melanoma	0.000652	0.00603	CcSEcCtD
Diphenhydramine—Constipation—Carmustine—melanoma	0.000649	0.006	CcSEcCtD
Diphenhydramine—Dyspepsia—Temozolomide—melanoma	0.000645	0.00597	CcSEcCtD
Diphenhydramine—Decreased appetite—Temozolomide—melanoma	0.000637	0.0059	CcSEcCtD
Diphenhydramine—Fatigue—Temozolomide—melanoma	0.000632	0.00585	CcSEcCtD
Diphenhydramine—Constipation—Temozolomide—melanoma	0.000627	0.0058	CcSEcCtD
Diphenhydramine—Feeling abnormal—Carmustine—melanoma	0.000625	0.00578	CcSEcCtD
Diphenhydramine—Asthenia—Bleomycin—melanoma	0.000624	0.00577	CcSEcCtD
Diphenhydramine—Chills—Docetaxel—melanoma	0.000616	0.0057	CcSEcCtD
Diphenhydramine—Feeling abnormal—Temozolomide—melanoma	0.000604	0.00559	CcSEcCtD
Diphenhydramine—Urticaria—Temozolomide—melanoma	0.000582	0.00539	CcSEcCtD
Diphenhydramine—Asthenia—Dactinomycin—melanoma	0.000582	0.00538	CcSEcCtD
Diphenhydramine—Diarrhoea—Dactinomycin—melanoma	0.000555	0.00513	CcSEcCtD
Diphenhydramine—Vomiting—Bleomycin—melanoma	0.000553	0.00511	CcSEcCtD
Diphenhydramine—Rash—Bleomycin—melanoma	0.000548	0.00507	CcSEcCtD
Diphenhydramine—Dermatitis—Bleomycin—melanoma	0.000547	0.00507	CcSEcCtD
Diphenhydramine—Asthenia—Carmustine—melanoma	0.000544	0.00504	CcSEcCtD
Diphenhydramine—Palpitations—Docetaxel—melanoma	0.000528	0.00488	CcSEcCtD
Diphenhydramine—Asthenia—Temozolomide—melanoma	0.000526	0.00487	CcSEcCtD
Diphenhydramine—Diarrhoea—Carmustine—melanoma	0.000519	0.0048	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—melanoma	0.000518	0.00479	CcSEcCtD
Diphenhydramine—Nausea—Bleomycin—melanoma	0.000516	0.00478	CcSEcCtD
Diphenhydramine—Vomiting—Dactinomycin—melanoma	0.000515	0.00477	CcSEcCtD
Diphenhydramine—Rash—Dactinomycin—melanoma	0.000511	0.00473	CcSEcCtD
Diphenhydramine—Orphenadrine—SCN10A—melanoma	0.000507	0.0805	CrCbGaD
Diphenhydramine—Dizziness—Carmustine—melanoma	0.000502	0.00464	CcSEcCtD
Diphenhydramine—Diarrhoea—Temozolomide—melanoma	0.000502	0.00464	CcSEcCtD
Diphenhydramine—Dry mouth—Docetaxel—melanoma	0.000497	0.0046	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—melanoma	0.000492	0.00455	CcSEcCtD
Diphenhydramine—Dizziness—Temozolomide—melanoma	0.000485	0.00449	CcSEcCtD
Diphenhydramine—Vomiting—Carmustine—melanoma	0.000482	0.00446	CcSEcCtD
Diphenhydramine—Nausea—Dactinomycin—melanoma	0.000481	0.00446	CcSEcCtD
Diphenhydramine—Rash—Carmustine—melanoma	0.000478	0.00443	CcSEcCtD
Diphenhydramine—Dermatitis—Carmustine—melanoma	0.000478	0.00442	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—melanoma	0.000477	0.00442	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—melanoma	0.000476	0.0044	CcSEcCtD
Diphenhydramine—Headache—Carmustine—melanoma	0.000475	0.0044	CcSEcCtD
Diphenhydramine—Vomiting—Temozolomide—melanoma	0.000466	0.00431	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—melanoma	0.000465	0.0043	CcSEcCtD
Diphenhydramine—Rash—Temozolomide—melanoma	0.000462	0.00428	CcSEcCtD
Diphenhydramine—Dermatitis—Temozolomide—melanoma	0.000462	0.00427	CcSEcCtD
Diphenhydramine—Headache—Temozolomide—melanoma	0.000459	0.00425	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—melanoma	0.000456	0.00422	CcSEcCtD
Diphenhydramine—Nausea—Carmustine—melanoma	0.000451	0.00417	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—melanoma	0.000441	0.00408	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—melanoma	0.000438	0.00405	CcSEcCtD
Diphenhydramine—Nausea—Temozolomide—melanoma	0.000435	0.00403	CcSEcCtD
Diphenhydramine—Somnolence—Docetaxel—melanoma	0.000433	0.00401	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—melanoma	0.000429	0.00397	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—melanoma	0.000424	0.00392	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—melanoma	0.00042	0.00389	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—melanoma	0.000417	0.00386	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—melanoma	0.000402	0.00372	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP1B1—melanoma	0.000399	0.0634	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—melanoma	0.000385	0.0611	CrCbGaD
Diphenhydramine—Reboxetine—ABCB1—melanoma	0.000362	0.0574	CrCbGaD
Diphenhydramine—Asthenia—Docetaxel—melanoma	0.00035	0.00324	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—melanoma	0.000334	0.00309	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—melanoma	0.000322	0.00298	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS2—melanoma	0.000318	0.0505	CrCbGaD
Diphenhydramine—Vomiting—Docetaxel—melanoma	0.00031	0.00287	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—melanoma	0.000307	0.00284	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—melanoma	0.000307	0.00284	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—melanoma	0.000305	0.00283	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—melanoma	0.00029	0.00268	CcSEcCtD
Diphenhydramine—Toremifene—ABCB1—melanoma	0.000287	0.0455	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—melanoma	0.000283	0.045	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—melanoma	0.000254	0.0404	CrCbGaD
Diphenhydramine—Clomifene—ABCB1—melanoma	0.000248	0.0393	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—melanoma	0.000244	0.0388	CrCbGaD
Diphenhydramine—Warfarin—ALB—melanoma	0.000217	0.0344	CrCbGaD
Diphenhydramine—Bepridil—ABCB1—melanoma	0.00018	0.0286	CrCbGaD
Diphenhydramine—Fentanyl—ABCB1—melanoma	0.000166	0.0263	CrCbGaD
Diphenhydramine—Phenytoin—ALB—melanoma	0.000157	0.025	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—melanoma	0.00015	0.0238	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—melanoma	0.00012	0.019	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—melanoma	0.000115	0.0183	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—melanoma	0.000115	0.0182	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—melanoma	0.000114	0.0181	CrCbGaD
Diphenhydramine—Methadone—ABCB1—melanoma	0.000114	0.018	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—melanoma	9.25e-05	0.0147	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—melanoma	8.89e-05	0.0141	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—melanoma	8.83e-05	0.014	CrCbGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—melanoma	1.58e-05	0.000121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CSF2—melanoma	1.58e-05	0.000121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF1—melanoma	1.58e-05	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GNA11—melanoma	1.58e-05	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.58e-05	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.56e-05	0.00012	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—FASN—melanoma	1.56e-05	0.00012	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—melanoma	1.56e-05	0.00012	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CSF2—melanoma	1.56e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF1—melanoma	1.56e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PRKCA—melanoma	1.55e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.55e-05	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—E2F1—melanoma	1.55e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—FASN—melanoma	1.55e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1B1—melanoma	1.55e-05	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CB—melanoma	1.54e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ERCC2—melanoma	1.54e-05	0.000118	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—melanoma	1.54e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC5A5—melanoma	1.53e-05	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—melanoma	1.53e-05	0.000118	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFRA—melanoma	1.53e-05	0.000118	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—melanoma	1.53e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—E2F1—melanoma	1.52e-05	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC5A5—melanoma	1.52e-05	0.000117	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ITGB3—melanoma	1.52e-05	0.000116	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKCA—melanoma	1.52e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	1.52e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFRA—melanoma	1.51e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ITGB3—melanoma	1.49e-05	0.000115	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCA—melanoma	1.49e-05	0.000115	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—melanoma	1.49e-05	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GNAQ—melanoma	1.48e-05	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD44—melanoma	1.48e-05	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAP2K2—melanoma	1.48e-05	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—melanoma	1.48e-05	0.000114	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—melanoma	1.47e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GNAQ—melanoma	1.47e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD44—melanoma	1.47e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—melanoma	1.46e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAP2K2—melanoma	1.46e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—melanoma	1.46e-05	0.000112	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—melanoma	1.44e-05	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.44e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP17A1—melanoma	1.43e-05	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.43e-05	0.000109	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—melanoma	1.42e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1B1—melanoma	1.42e-05	0.000109	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—melanoma	1.41e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.41e-05	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—melanoma	1.41e-05	0.000108	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1B1—melanoma	1.41e-05	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAC1—melanoma	1.41e-05	0.000108	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—melanoma	1.4e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.39e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—melanoma	1.39e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—melanoma	1.39e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAC1—melanoma	1.38e-05	0.000106	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—melanoma	1.38e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.36e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GNA11—melanoma	1.35e-05	0.000104	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—melanoma	1.35e-05	0.000103	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—melanoma	1.34e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—melanoma	1.33e-05	0.000102	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—melanoma	1.33e-05	0.000102	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—FASN—melanoma	1.32e-05	0.000101	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—melanoma	1.3e-05	9.98e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—melanoma	1.29e-05	9.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—melanoma	1.27e-05	9.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—melanoma	1.27e-05	9.74e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GNAQ—melanoma	1.26e-05	9.64e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD44—melanoma	1.26e-05	9.64e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—melanoma	1.26e-05	9.64e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—melanoma	1.24e-05	9.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.24e-05	9.55e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FN1—melanoma	1.24e-05	9.53e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.23e-05	9.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FN1—melanoma	1.22e-05	9.37e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—melanoma	1.22e-05	9.36e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.22e-05	9.35e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH1—melanoma	1.21e-05	9.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—melanoma	1.21e-05	9.32e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—melanoma	1.21e-05	9.27e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1B1—melanoma	1.2e-05	9.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH1—melanoma	1.19e-05	9.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD80—melanoma	1.19e-05	9.13e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KIT—melanoma	1.19e-05	9.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—melanoma	1.19e-05	9.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—melanoma	1.19e-05	9.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—melanoma	1.19e-05	9.12e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—melanoma	1.17e-05	9.01e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—melanoma	1.17e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PRKCA—melanoma	1.17e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD80—melanoma	1.17e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—melanoma	1.17e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—melanoma	1.17e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—melanoma	1.17e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—melanoma	1.17e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KIT—melanoma	1.17e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—melanoma	1.17e-05	8.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ERCC2—melanoma	1.16e-05	8.92e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—melanoma	1.16e-05	8.91e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—melanoma	1.16e-05	8.9e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—melanoma	1.15e-05	8.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—melanoma	1.15e-05	8.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—melanoma	1.14e-05	8.73e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—melanoma	1.12e-05	8.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—melanoma	1.12e-05	8.57e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—melanoma	1.1e-05	8.43e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—melanoma	1.09e-05	8.35e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—melanoma	1.09e-05	8.33e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK1—melanoma	1.08e-05	8.31e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—melanoma	1.08e-05	8.31e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PRKCA—melanoma	1.08e-05	8.27e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—melanoma	1.07e-05	8.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ERCC2—melanoma	1.07e-05	8.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PRKCA—melanoma	1.07e-05	8.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—melanoma	1.07e-05	8.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.06e-05	8.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—melanoma	1.06e-05	8.17e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.06e-05	8.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ERCC2—melanoma	1.06e-05	8.13e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—melanoma	1.05e-05	8.09e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—melanoma	1.05e-05	8.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAP2K1—melanoma	1.05e-05	8.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—melanoma	1.04e-05	8.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	1.03e-05	7.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.03e-05	7.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.03e-05	7.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—melanoma	1.02e-05	7.85e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.02e-05	7.81e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—melanoma	1.01e-05	7.76e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—melanoma	1.01e-05	7.72e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF2—melanoma	9.99e-06	7.67e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—melanoma	9.92e-06	7.61e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF2—melanoma	9.83e-06	7.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.62e-06	7.39e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—melanoma	9.42e-06	7.23e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—melanoma	9.39e-06	7.21e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—melanoma	9.35e-06	7.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—melanoma	9.3e-06	7.14e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	9.24e-06	7.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—melanoma	9.22e-06	7.08e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—melanoma	9.22e-06	7.08e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—melanoma	9.2e-06	7.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—melanoma	9.17e-06	7.04e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PRKCA—melanoma	9.12e-06	7.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—melanoma	9.1e-06	6.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—melanoma	9.07e-06	6.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ERCC2—melanoma	9.05e-06	6.95e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—melanoma	8.95e-06	6.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—melanoma	8.85e-06	6.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.77e-06	6.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—melanoma	8.74e-06	6.71e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—melanoma	8.69e-06	6.67e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—melanoma	8.6e-06	6.61e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—melanoma	8.55e-06	6.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—melanoma	8.54e-06	6.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—melanoma	8.45e-06	6.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—melanoma	8.44e-06	6.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—melanoma	8.4e-06	6.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—melanoma	8.37e-06	6.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—melanoma	8.36e-06	6.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—melanoma	8.36e-06	6.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—melanoma	8.31e-06	6.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—melanoma	8.31e-06	6.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—melanoma	8.23e-06	6.32e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—melanoma	8.22e-06	6.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—melanoma	8.18e-06	6.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—melanoma	8.15e-06	6.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—melanoma	8.14e-06	6.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—melanoma	8.07e-06	6.2e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—melanoma	8.07e-06	6.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—melanoma	8.06e-06	6.19e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—melanoma	8.04e-06	6.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—melanoma	8.02e-06	6.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—melanoma	7.96e-06	6.11e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—melanoma	7.94e-06	6.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—melanoma	7.91e-06	6.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—melanoma	7.88e-06	6.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—melanoma	7.86e-06	6.04e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKB1—melanoma	7.82e-06	6.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—melanoma	7.78e-06	5.97e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—melanoma	7.75e-06	5.95e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—melanoma	7.74e-06	5.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKB1—melanoma	7.7e-06	5.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—melanoma	7.67e-06	5.89e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—melanoma	7.66e-06	5.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—melanoma	7.55e-06	5.79e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.5e-06	5.76e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—melanoma	7.43e-06	5.71e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—melanoma	7.42e-06	5.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—melanoma	7.35e-06	5.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—melanoma	7.32e-06	5.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—melanoma	7.26e-06	5.57e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—melanoma	7.15e-06	5.49e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—melanoma	7.14e-06	5.48e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—melanoma	7.1e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—melanoma	7.03e-06	5.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—melanoma	7.03e-06	5.4e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—melanoma	7.01e-06	5.39e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—melanoma	6.99e-06	5.36e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—melanoma	6.96e-06	5.35e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—melanoma	6.92e-06	5.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—melanoma	6.9e-06	5.3e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—melanoma	6.9e-06	5.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—melanoma	6.72e-06	5.16e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—melanoma	6.61e-06	5.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—melanoma	6.53e-06	5.02e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—melanoma	6.46e-06	4.96e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—melanoma	6.43e-06	4.94e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—melanoma	6.41e-06	4.92e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—melanoma	6.41e-06	4.92e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK1—melanoma	6.39e-06	4.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—melanoma	6.39e-06	4.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—melanoma	6.35e-06	4.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK1—melanoma	6.29e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—melanoma	6.29e-06	4.83e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—melanoma	6.28e-06	4.82e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—melanoma	6.25e-06	4.8e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—melanoma	6.2e-06	4.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—melanoma	6.07e-06	4.66e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—melanoma	6.07e-06	4.66e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—melanoma	6.04e-06	4.63e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—melanoma	5.94e-06	4.56e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—melanoma	5.83e-06	4.47e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—melanoma	5.67e-06	4.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—melanoma	5.59e-06	4.29e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—melanoma	5.55e-06	4.26e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—melanoma	5.54e-06	4.25e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—melanoma	5.48e-06	4.2e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—melanoma	5.46e-06	4.19e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—melanoma	5.43e-06	4.17e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—melanoma	5.37e-06	4.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—melanoma	5.28e-06	4.05e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—melanoma	5.13e-06	3.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—melanoma	5.05e-06	3.88e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—melanoma	4.91e-06	3.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—melanoma	4.83e-06	3.71e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—melanoma	4.73e-06	3.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—melanoma	4.63e-06	3.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—melanoma	4.53e-06	3.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—melanoma	4.46e-06	3.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—melanoma	4.28e-06	3.29e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—melanoma	3.94e-06	3.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—melanoma	3.91e-06	3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—melanoma	3.5e-06	2.69e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—melanoma	3.34e-06	2.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—melanoma	3.22e-06	2.47e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—melanoma	3.19e-06	2.45e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—melanoma	2.73e-06	2.09e-05	CbGpPWpGaD
